PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Bruker Corporation (BRKR)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US1167941087

CUSIP

116794108

Sector

Healthcare

IPO Date

Aug 4, 2000

Highlights

Market Cap

$8.76B

EPS (TTM)

$2.07

PE Ratio

27.93

PEG Ratio

3.64

Total Revenue (TTM)

$3.24B

Gross Profit (TTM)

$1.58B

EBITDA (TTM)

$533.60M

Year Range

$48.03 - $94.64

Target Price

$74.18

Short %

2.97%

Short Ratio

1.93

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
BRKR vs. STE BRKR vs. SPY BRKR vs. AMAT BRKR vs. VOO BRKR vs. MSFT
Popular comparisons:
BRKR vs. STE BRKR vs. SPY BRKR vs. AMAT BRKR vs. VOO BRKR vs. MSFT

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Bruker Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-30.00%-20.00%-10.00%0.00%10.00%JulyAugustSeptemberOctoberNovemberDecember
-16.12%
7.36%
BRKR (Bruker Corporation)
Benchmark (^GSPC)

Returns By Period

Bruker Corporation had a return of -24.53% year-to-date (YTD) and -23.79% in the last 12 months. Over the past 10 years, Bruker Corporation had an annualized return of 11.32%, while the S&P 500 benchmark had an annualized return of 11.10%, indicating that Bruker Corporation performed slightly bigger than the benchmark.


BRKR

YTD

-24.53%

1M

14.69%

6M

-16.77%

1Y

-23.79%

5Y*

1.69%

10Y*

11.32%

^GSPC (Benchmark)

YTD

24.66%

1M

0.49%

6M

8.64%

1Y

26.56%

5Y*

13.06%

10Y*

11.10%

Monthly Returns

The table below presents the monthly returns of BRKR, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-2.68%21.09%8.55%-16.96%-16.02%-2.52%7.37%-1.85%2.78%-18.03%2.37%-24.53%
20232.59%-1.64%14.39%0.37%-12.61%6.98%-7.03%-4.47%-5.03%-8.51%14.28%12.89%7.82%
2022-20.63%5.73%-8.63%-10.59%8.77%0.45%9.23%-18.24%-5.25%16.55%9.09%1.39%-18.29%
20216.95%5.34%5.48%6.60%1.40%9.42%8.25%7.42%-11.56%2.82%0.91%3.61%55.35%
2020-2.94%-11.95%-17.60%9.65%10.17%-6.01%9.69%-5.74%-5.40%7.02%19.06%6.96%6.58%
201917.77%8.98%0.71%0.42%8.32%19.58%-4.20%-9.70%1.76%1.30%15.12%-0.43%71.85%
20183.76%-13.93%-2.25%-1.30%2.51%-3.94%11.57%9.94%-5.99%-6.34%5.91%-10.17%-12.82%
201712.04%1.77%-3.24%4.54%11.56%6.15%-0.55%1.57%2.27%5.55%12.04%-2.33%62.96%
2016-7.99%16.35%7.93%1.07%-6.71%-13.73%9.59%-10.27%1.48%-9.54%10.69%-6.45%-12.16%
2015-3.87%0.90%-2.94%2.65%4.64%2.87%3.14%-12.68%-10.61%11.81%23.24%7.20%23.70%
20142.93%11.74%0.22%-9.35%1.40%15.85%-6.35%-11.75%-7.70%11.96%-7.48%2.29%-0.76%
201310.71%3.97%8.89%-6.96%-6.98%-2.30%10.96%11.83%3.04%-0.94%-5.45%2.22%29.74%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of BRKR is 18, meaning it’s performing worse than 82% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of BRKR is 1818
Overall Rank
The Sharpe Ratio Rank of BRKR is 1414
Sharpe Ratio Rank
The Sortino Ratio Rank of BRKR is 1616
Sortino Ratio Rank
The Omega Ratio Rank of BRKR is 1717
Omega Ratio Rank
The Calmar Ratio Rank of BRKR is 1818
Calmar Ratio Rank
The Martin Ratio Rank of BRKR is 2626
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Bruker Corporation (BRKR) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for BRKR, currently valued at -0.67, compared to the broader market-4.00-2.000.002.00-0.672.12
The chart of Sortino ratio for BRKR, currently valued at -0.83, compared to the broader market-4.00-2.000.002.004.00-0.832.83
The chart of Omega ratio for BRKR, currently valued at 0.90, compared to the broader market0.501.001.502.000.901.39
The chart of Calmar ratio for BRKR, currently valued at -0.53, compared to the broader market0.002.004.006.00-0.533.13
The chart of Martin ratio for BRKR, currently valued at -0.98, compared to the broader market0.0010.0020.00-0.9813.67
BRKR
^GSPC

The current Bruker Corporation Sharpe ratio is -0.67. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Bruker Corporation with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JulyAugustSeptemberOctoberNovemberDecember
-0.67
1.83
BRKR (Bruker Corporation)
Benchmark (^GSPC)

Dividends

Dividend History

Bruker Corporation provided a 0.36% dividend yield over the last twelve months, with an annual payout of $0.20 per share. The company has been increasing its dividends for 7 consecutive years.


0.20%0.30%0.40%0.50%0.60%0.70%0.80%$0.00$0.05$0.10$0.15$0.2020162017201820192020202120222023
Dividends
Dividend Yield
PeriodTTM20232022202120202019201820172016
Dividend$0.20$0.20$0.20$0.16$0.16$0.16$0.16$0.16$0.16

Dividend yield

0.36%0.27%0.29%0.19%0.30%0.31%0.54%0.47%0.76%

Monthly Dividends

The table displays the monthly dividend distributions for Bruker Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024$0.00$0.05$0.00$0.00$0.00$0.05$0.00$0.05$0.00$0.00$0.00$0.05$0.20
2023$0.00$0.05$0.00$0.00$0.05$0.00$0.00$0.05$0.00$0.00$0.05$0.00$0.20
2022$0.00$0.05$0.00$0.00$0.05$0.00$0.00$0.05$0.00$0.00$0.05$0.00$0.20
2021$0.00$0.00$0.04$0.00$0.04$0.00$0.00$0.04$0.00$0.00$0.04$0.00$0.16
2020$0.00$0.00$0.04$0.00$0.04$0.00$0.00$0.04$0.00$0.00$0.04$0.00$0.16
2019$0.00$0.00$0.04$0.00$0.04$0.00$0.00$0.04$0.00$0.00$0.04$0.00$0.16
2018$0.00$0.00$0.04$0.00$0.00$0.04$0.00$0.04$0.00$0.00$0.04$0.00$0.16
2017$0.00$0.00$0.04$0.00$0.00$0.04$0.00$0.04$0.00$0.00$0.00$0.04$0.16
2016$0.04$0.00$0.00$0.04$0.00$0.00$0.04$0.00$0.00$0.04$0.16

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%20.0%0.4%
Bruker Corporation has a dividend yield of 0.36%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
200.0%400.0%600.0%800.0%8.2%
Bruker Corporation has a payout ratio of 8.16%, which is below the market average. This means Bruker Corporation returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-41.21%
-3.66%
BRKR (Bruker Corporation)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Bruker Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Bruker Corporation was 94.83%, occurring on Mar 12, 2003. Recovery took 4103 trading sessions.

The current Bruker Corporation drawdown is 41.21%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-94.83%Sep 1, 2000631Mar 12, 20034103Jun 28, 20194734
-48.74%Mar 22, 2024168Nov 19, 2024
-46.31%Sep 7, 2021266Sep 26, 2022363Mar 7, 2024629
-41.49%Jan 17, 202052Apr 1, 2020173Dec 7, 2020225
-22.01%Jul 8, 201928Aug 14, 201974Nov 27, 2019102

Volatility

Volatility Chart

The current Bruker Corporation volatility is 14.76%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%JulyAugustSeptemberOctoberNovemberDecember
14.76%
3.62%
BRKR (Bruker Corporation)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Bruker Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an assessment of the market value of Bruker Corporation compared to its peers in the Medical Devices industry.


PE Ratio
50.0100.0150.0200.027.9
The chart displays the price to earnings (P/E) ratio for BRKR in comparison to other companies of the Medical Devices industry. Currently, BRKR has a PE value of 27.9. This PE ratio falls in the average range for the industry.
PEG Ratio
-60.0-40.0-20.00.020.040.060.080.03.6
The chart displays the price to earnings to growth (PEG) ratio for BRKR in comparison to other companies of the Medical Devices industry. Currently, BRKR has a PEG value of 3.6. This PEG ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Bruker Corporation.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab